Results 91 to 100 of about 175,728,522 (204)
Esophagogastric adenocarcinoma [PDF]
Iuliu Hatieganu University of Medicine and Pharmacy, Cluj, Romania, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016Introduction: The adenocarcinoma of esophagogastric junction includes three anatomical entities ...
Cimpan, Claudia Mihaela +1 more
core +1 more source
CONTEXT: Esophagogastric junction adenocarcinoma has an aggressive behavior, and TNM (UICC) staging is not always accurate enough to categorize patient's outcome.
Dárcio Matenhauer Lehrbach +5 more
doaj +1 more source
Adenocarcinoma of the gastroesophageal junction (AEG) has become increasingly common in Western and Asian populations. Surgical resection is the mainstay of treatment for AEG; however, determining the distance from the upper edge of the tumor to the ...
Kai Yin, Mingming Nie, Tao Pang
core +1 more source
Esophagopericardial fistula as a rare complication after total gastrectomy for cancer
Background Esophagopericardial fistula is a rare but life-threatening complication of benign, malignant or traumatic esophageal disease. It is most commonly associated with benign etiology and carries a high mortality rate which increases with delay in ...
Athanasopoulos Panayiotis +7 more
doaj +1 more source
Expression of MUC2 Glycoprotein Antibody and Vascular Endothelial Growth Factor in Barrett’s Mucosa
Higher expression of the mucin 2 (MUC2) glycoprotein and vascular endothelial growth factor (VEGF) in Barrett’s mucosa may be associated with a higher risk of esophageal adenocarcinoma development.
Melanija Ražov Radas
doaj +1 more source
Prevalência de metaplasia intestinal na junção esofagogástrica no Instituto de Endiscopia do Planalto [PDF]
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Ciências Médicas, Florianópolis, 2006.Os estudos de prevalência de metaplasia intestinal na junção esofagogástrica são recentes na ...
Guzatti Fiho, Osmar
core
Top 5 Advances in the Last 50 Years: Malignant Gastric and Esophageal Surgery
World Journal of Surgery, Volume 50, Issue 8, Page 2081-2084, August 2026.
Luís Santos Castro, Lorenzo Ferri
wiley +1 more source
Immunotherapy as a new perspective for the therapy of esophageal cancer
The therapeutic landscape in nearly every therapeutic line in advanced/metastatic patients with squamous cell carcinoma (SCC) and esophagogastric adenocarcinoma (EGC) is enriched by recent approvals of immune checkpoint inhibitors (ICIs).
Huber Yvonne +2 more
doaj +1 more source
Esophagectomy remains a challenging procedure both for the patient and the surgeon. Patient selection and evaluation aims at preventing individuals unfit for surgery or without chance of cure from this operation.
K. Tobias, E. Beckurts
doaj +1 more source
Recent updates of therapeutic strategy of esophagogastric junction adenocarcinoma
The incidence of esophagogastric junction (EGJ) adenocarcinoma has been increasing in Asian countries. Despite the recent advances in multidisciplinary treatments, EGJ adenocarcinoma remains aggressive with unfavorable outcomes.
Okamura, Akihiko +7 more
core

